Autism Spectrum Disorders
|
0.400 |
Biomarker
|
disease |
CTD_human |
Notwithstanding complexities, our results further implicate the SHANK3-NLGN4-NRXN1 postsynaptic density genes and also identify novel loci at DPP6-DPP10-PCDH9 (synapse complex), ANKRD11, DPYD, PTCHD1, 15q24, among others, for a role in ASD susceptibility.
|
18252227 |
2008 |
Autism Spectrum Disorders
|
0.400 |
Biomarker
|
disease |
BEFREE |
Notwithstanding complexities, our results further implicate the SHANK3-NLGN4-NRXN1 postsynaptic density genes and also identify novel loci at DPP6-DPP10-PCDH9 (synapse complex), ANKRD11, DPYD, PTCHD1, 15q24, among others, for a role in ASD susceptibility.
|
18252227 |
2008 |
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4
|
0.400 |
SusceptibilityMutation
|
disease |
CLINVAR |
|
|
|
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4
|
0.400 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Mental Retardation, X-Linked Nonsyndromic
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Thalamic reticular impairment underlies attention deficit in Ptchd1(Y/-) mice.
|
27007844 |
2016 |
Mental Retardation, X-Linked Nonsyndromic
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions.
|
25356970 |
2015 |
Mental Retardation, X-Linked Nonsyndromic
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability.
|
26350204 |
2015 |
Mental Retardation, X-Linked Nonsyndromic
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Phenotypic spectrum associated with PTCHD1 deletions and truncating mutations includes intellectual disability and autism spectrum disorder.
|
25131214 |
2015 |
Mental Retardation, X-Linked
|
0.300 |
Biomarker
|
disease |
CTD_human |
Deletion in Xp22.11: PTCHD1 is a candidate gene for X-linked intellectual disability with or without autism.
|
21091464 |
2011 |
Mental Retardation, X-Linked 1
|
0.300 |
GeneticVariation
|
disease |
ORPHANET |
Deletion in Xp22.11: PTCHD1 is a candidate gene for X-linked intellectual disability with or without autism.
|
21091464 |
2011 |
Profound Mental Retardation
|
0.300 |
Biomarker
|
disease |
CTD_human |
Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability.
|
20844286 |
2010 |
Mental Retardation, Psychosocial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability.
|
20844286 |
2010 |
Mental deficiency
|
0.300 |
Biomarker
|
disease |
CTD_human |
Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability.
|
20844286 |
2010 |
Mental Retardation, X-Linked 1
|
0.300 |
GeneticVariation
|
disease |
ORPHANET |
Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability.
|
20844286 |
2010 |
Mental Retardation, X-Linked Nonsyndromic
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability.
|
20844286 |
2010 |
Attention Deficit Disorder
|
0.210 |
GeneticVariation
|
disease |
BEFREE |
TRN-restricted deletion of Ptchd1 leads to attention deficits and hyperactivity, both of which are rescued by pharmacological augmentation of SK channel activity.
|
27007844 |
2016 |
Attention Deficit Disorder
|
0.210 |
Biomarker
|
disease |
MGD |
TRN-restricted deletion of Ptchd1 leads to attention deficits and hyperactivity, both of which are rescued by pharmacological augmentation of SK channel activity.
|
27007844 |
2016 |
Attention deficit hyperactivity disorder
|
0.120 |
Biomarker
|
disease |
BEFREE |
Our findings indicate that Ptchd1 KO mice can be used as an animal model of human ADHD and/or ASD, and KP metabolites are potential diagnostic biomarkers for neurodevelopmental disorders.
|
31515500 |
2019 |
Attention deficit hyperactivity disorder
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
TRN-restricted deletion of Ptchd1 leads to attention deficits and hyperactivity, both of which are rescued by pharmacological augmentation of SK channel activity.
|
27007844 |
2016 |
Attention deficit hyperactivity disorder
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Autistic behavior
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Our findings suggest that hemizygous PTCHD1 loss of function causes an X-linked neurodevelopmental disorder with a strong propensity to autistic behaviors.
|
25131214 |
2015 |
Autistic behavior
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Movement Disorders
|
0.100 |
CausalMutation
|
group |
CLINVAR |
Phenotypic spectrum associated with PTCHD1 deletions and truncating mutations includes intellectual disability and autism spectrum disorder.
|
25131214 |
2015 |
Movement Disorders
|
0.100 |
CausalMutation
|
group |
CLINVAR |
Contribution of common and rare variants of the PTCHD1 gene to autism spectrum disorders and intellectual disability.
|
25782667 |
2015 |
Muscle hypotonia
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Phenotypic spectrum associated with PTCHD1 deletions and truncating mutations includes intellectual disability and autism spectrum disorder.
|
25131214 |
2015 |